Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Determine which IRA is best for low-cost index funds to minimize fees and maximize long-term growth across portfolios.
27,103 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Bank earnings just dropped fresh clues about how Americans are spending, borrowing, and saving. This deep dive breaks...
Investigating the royal bank (ry) 2026 Q2 results reveals how the lender is balancing growth across retail, wealth, a...
DATs openly hold crypto on their balance sheets, letting investors gain exposure by buying stock. This piece explains...
As NVIDIA readies its GTC keynote, memory names MU and SNDK swing on speculation about a new inference chip that coul...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...
With a 15-day deadline to resolve Iran tensions, U.S. markets brace for a volatile April as traders weigh oil, stocks...
ProShares Ultra Bloomberg Crude Oil 2x (UCO) has surged about 125% this year, yet traders warn a hidden structural ri...
Treasury yields climbed past 4.6% as inflation signals remained stubborn. Here’s how JBND could respond and what inve...
American Express is scrapping its long-standing unit-by-unit bonus race. The company now ties executive pay to overal...
Market chatter about a SpaceX mega-IPO is heating up, but the professor tracks every just IPO, warning that lofty val...
Investors are prioritizing explicit AI attribution over beating earnings estimates, signaling a shift in how stocks a...